Evidence map›Paper›PMID 35564194›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Comparative Study of Pd-Ni Bimetallic Catalysts Supported on UiO-66 and UiO-66-NH

Lili Liu, Lei Yu, Xiaojing Zhou, Chunling Xin, Songyuan Sun, Zhidong Liu, Jinyu Zhang, Ying Liu, Xishi Tai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. MOF-Derived ZrOMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lili LiuSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.ORCID 0000-0002-3062-0783
Lei YuSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Xiaojing ZhouSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Chunling XinSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Songyuan SunSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Zhidong LiuSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Jinyu ZhangShandong Huazhiyuan Testing Co., Ltd., Weifang 261061, China.
Ying LiuSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.
Xishi TaiSchool of Chemistry & Chemical Engineering and Environmental Engineering, Weifang University, Weifang 261061, China.ORCID 0000-0002-0050-1900
Weifang University · CN

Funding

High-tech Industrial Development Zone Science and Technology Huimin Plan of Weifang 2019KJHM18National Natural Science Foundation of China 21802104Natural Science Foundation of Shandong Province ZR2017MB056Technology Research and Development Program of Weifang 2021GX007
6 · The paper itself

Abstract

Selective hydrogenation of 1,3-butadiene (BD) is regarded as the most promising route for removing BD from butene streams. Bimetallic Pd-Ni catalysts with changed Pd/Ni molar ratios and monometallic Pd catalysts were synthesized using two differently structured metal-organic framework supports: UiO-66 and UiO-66-NH

Indexed as

1,3-butadiene hydrogenationPd–Ni bimetallic catalystsUiO-66UiO-66-NH2

Identifiers

PMID35564194
PMCPMC9105395
OpenAlexW4224992026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.